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Selective Recovery of 13-Galactosidase With Charged Fusion Tails
Using Ion-Exchange Membranes
ERIKA A. THIEM and MENG H. HENG
Department of Chemical Engineering, 231 Sweeney Hall, Iowa State University, Ames, IA 50011

We explored the feasibility of attaching charged tails to a target protein, in this case (3-galactosidase, for selective recovery. In this
process, an ion-exchange membrane was used for selective binding and release of (3-galactosidase with the attached purification fusions.
Strength of binding and purity of eluate increased with increasing tail length. In addition, activity yield was improved with the implementation of an intermediate partial elution recycle procedure.
INDEX DESCRIPTORS: fusion proteins, purification fusions, protein purification, ion-exchange, (3-galactosidase

The ability to generically manipulate proteins has made it possible
to mass produce those of interest. This breakthrough has lead to many
technological advancements in science and industry. However, problems arise when genetically engineered proteins need to be separated
and purified. The cost associated with separating and purifying proteins to the standard of industrial use is a major production cost. In
fact, purification and recovery costs can account for as much as 80 percent of the total manufacturing cost in the large-scale production of
recombinant protein products (1). Thus, without new downstream
processing techniques, the abundance of genetically engineered proteins may lead to little profitability.
In an effort to keep pace with modern technology, new procedures
are being developed for downstream processing in the areas of separation and purification. Ion-exchange is a technique which has been in
use for many years. The bind and release process allows proteins with
a certain ionic charge to be separated from others having the opposite
charge or no charge. Recent developments in biotechnology utilize
genetically engineered proteins in ion-exchange procedures, in particular proteins with attached purification fusions. Purification fusions
enhance selectivity of ion-exchange operations as well as facilitate difficult separations. In designing fusion "rails", additional charges supplied by charged amino acids are used to provide the fusion with a
distinctive charge which readily facilitates purification. The fusion
protein is made by combining the DNA of the target protein with
DNA coding for the fusion tail. The result is the expression of the
fusion tail in the target protein.
For this work, a microporous membrane was selected as the ionexchange vehicle for application with the purification fusions.
Previous research in our laboratory has taken advantage of negativelycharged fusion proteins in examining other ion-exchange separation
techniques (2,3). Cationic polyelectrolyte precipitation and aqueous
two-phase extraction are two separation methods in which increased
selectivity in separation was seen with the purification fusions. The
decision to explore ion-exchange membranes for selective separation
was based on its low cost, ease of use, and scale-up potential. The
membrane provided a uniform matrix that allowed rapid binding
kinetics without problems of diffusion or flow problems common
with packed bed or chromatographic separations.
The membrane was used in studying a model protein separation
system where 13-galacrosidase was recovered from cell extracts pre-

BGCDl ... Gin Lys I Gly Asp Pro Met Ala Tyr
BGCD5 ... Gin Lys I Gly Asp Pro (Asp)4 Ser Tyr
BGCDll ... Gin Lys I Gly Asp Pro (Asp) 10 Ser Tyr
Fig. 1 Amino Acid Sequences for Purification Fusions.

pared with fusion tails. Prior research (4) has shown success in the use
of purification fusions to enhance selectivity using hollow fiber ionexchange membranes (HFIEM). Over six fold enrichment was
observed when the HFIEM was used for ion-exchange. Similar results
were expected with the ion-exchange membrane cartridge.
MATERIALS AND METHODS

Fermentation and Extraction
The fusion tails were produced from Escherichia coli strain Yl089-l
with coding for 13-galactosidase. The fusion tails were attached at the
carboxyl terminus of the 13-galactosidase and consisted of a series of
amino acids with asparrates supplying the negative charge. Three
purification fusions of various lengths; BGCDl, BGCD5 and
BGCDl 1 had been prepared previously (5). BGCDl was used as a
control and contained one additional asparrate due to the restriction
sire. Four more aspartates were fused to BGCD5 and 10 more to
BGCDl 1. Figure 1 shows the specific sequences for each purification
fusion tail. From typical pK values for amino acids in proteins, net
charges of the fusion tails were estimated to be -22.48, -37.72 and
-60.57 for BGCDl, BGCD5 and BGCDl 1 respectively with the
wild type having a net charge of-18.4. A cleavage site exists between
the first aspartate in the chain and praline to allow for removal of the
tail. Tyrosine allows for ultraviolet detection.
The cells were grown in Luria-Bertani medium and fermented for
8 to 9 hours in an environmental shaker (37°C and 100 rpm). The
cells were then harvested by centrifugation (4°C and 15000 g). After
10 minutes of centrifugation, the cells were washed with a neutral
Tris-HCl buffer and recentrifuged. At this stage the cells were stored
at -70°C until ready for use.
The cell walls were ruptured by sonicarion (Heat Systems Wl85
Sonifier, Ultrasonics Inc., Plainview, NY) to extract the protein from
inside the cell. Six cycles of 30 second sonification followed by a 30
second cooling period were performed in a cold salt water bath. Cell
debris was removed by centrifugation (4°C and 23000 g) for 30 minutes. The filtered supernatants were then adjusted to 10 units/ml by
diluting them with a potassium phosphate buffer containing 2-mercaptoethanol and magnesium chloride, pH 5.7 (Sigma Chemical, St.
Louis, MO).
Membrane Ion-Exchange Operation
The adjusted cell extracts were passed through a microporous, ionexchange membrane enclosed in a polypropylene housing (ActiDisk ™Cartridge, FMC Corp., Rockland, ME). A matrix of quaternary amine came installed on the membrane to supply the fixed positive charge. Prior to loading the cartridge the membrane was equilibrated by washing with 0.089M potassium phosphate buffer (0. lM
ionic strength, pH 6). The wash was fed by a peristaltic pump at a
flow rate of 2 ml/min for 10 minutes. Twelve milliliters of the cell
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extract were prepared and a 2 ml sample of the feed was reserved.
The remaining 10 ml were loaded onto the membrane, also at a rate
of 2 ml/min. The apparatus assembly is pictured schematically in figure 2.
After all of the feed was loaded onto the membrane, it was washed
with 20 ml of the potassium phosphate buffer previously mentioned.
The wash cleansed the membrane of any loosely-bound protein.

Peristaltic
Pump

serum albumin standard. Enzyme activity was monitored by a timed
assay where o-nitrophenyl-f3-D-galactoside (ONPG), was hydrolyzed
by the f3-galactosidase. One unit of activity is defined as the amount
necessary to hydrolyze one micromole of ONPG to o-nitrophenol
and galactose per minute at pH 7 .3 and 37°C.
Recycle With Intermediate Partial Elution
In later runs a recycle was implemented to increase the activity
yield. The cartridge was prepared, loaded and washed as was done
previously. At this point the membrane was eluted with 3 ml of the
potassium phosphate salt solution via a syringe. The ionic strength of
the elutant depended on the number of aspartates in the fusion tail.
BGCDl was eluted with 0.2M solution, BGCD5 with 0.3M and
0.4M for BGCDl 1. The increasing concentration reflected the
increase in binding strength with tail length as discovered in our initial runs. With the membrane eluted, the feed was recycled and the
cartridge was washed again with 20 ml of potassium phosphate
buffer. The protein was then eluted through the step gradient procedure as before.
The purpose behind the partial elution was to remove any undesired proteins and create additional space on the membrane surface
for the successful binding of more f3-galactosidase. In addition, an
accompanying reduction of undesired protein components in the
final product would be favorable.
RESULTS AND DISCUSSION

Sample
Reservoir

Effluent (UV Anaylsis)

Fig. 2. Apparatus assembly with FMC QUAT. Courtesy of FMC
Corporation, Pine Brook, NJ.

Step Gradient Elution
Following the wash, the protein was removed from the membrane
by a series of elutions. Buffer solutions were prepared by adding sodium chloride to the potassium phosphate wash buffer with ionic
strengths ranging from 0.2 to 1.1 M. A step gradient elution was
performed by injecting the buffers through the cartridge in 3 ml
aliquots. By the time the 1.1 M solution was injected, nearly all of
the protein was eluted. The individual effluents were analyzed for
protein and activity content.

The selectivity in this ion-exchange operation can occur either
during the binding or release of the protein. Selectivity enhancement
provided by the fusion tails was examined in both cases.
Selective binding took place as a result of the intermediate partial
elution. In this process the intermediate elution caused all looselybound proteins to be eluted from the membrane. In addition,
unwanted, neutral and positively charged ions were rinsed through.
Hence, the membrane was cleaned and cleared in preparation for the
reapplication of the feed during the recycle.
The activity recovered in the effluent increased significantly with
the recycle procedure. For example, an initial run ofBGCDl resulted
in an activity recovery of 39 U/ml. In contrast, when the BGCDl
feed was recycled, the activity recovered rose to 55 U/ml. Figure 3
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Cartridge Storage
The cartridge was sterilized by washing with a 25 ml sample each
of deionized water and 70% methanol. The disk was dried by passing
air through a syringe and stored at room temperature for reuse.
Assays
Protein content and activity assays were performed immediately
afrer the step gradient elution. A dye-binding assay was performed to
determine protein content and concentration. Coomassie Brilliant
Blue G-250 stain (Bio-Rad, Richmond, CA) was used with a bovine

0

BGCD1

BGCD1
Recycled

BGCDS BGCDS BGCD11 BGCD11
Recycled
Recycled

Fig. 3. Activity recovery with intermediate elution and recycle procedure.
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shows the relationship between the increased activity and the intermediate elution procedure. The first column of each set shows the
amount of activity recovered without the recycle procedure and the
second column corresponds to the amount of recovered activity with
the feed recycled. Some of the activity was never recovered and may
have been lost due to inactivation or remained bound to the membrane during elution. Inactivation occurred when the enzyme was
allowed to sit at room temperature for lengthy periods of time. In a
measure to reduce the procedure time, the two, 20 ml buffer washes
were performed using a syringe rather than the peristaltic pump.
This step reduced the length of the recycle procedure and the assay
results showed less missing activity.
With the implementation of the intermediate partial elution recycle procedure, an increase in product yield was seen when compared
to the single pass procedure. More active 13-galactosidase was recovered in the elutions than without the recycle. However, no increase in
specific activity was seen for the recycled runs.
Selective release was enhanced through the use of the step gradient
elution. Each fusion showed a peak at the ionic strength Omax>
required for eluting the fraction with the maximum specific activity.
The Imax values remained quite reproducible throughout the battery of runs. An expected correlation between the fusion tail length
and the Imax peak was soon proven; with the increase of aspartates in
the tail the ionic strength required to release the protein increased.
This can be attributed to the additional charge the aspartates provide
to the fusion tails.
Although protein was eluted throughout the gradient steps, at
Imax the majority of the protein was washed off. Specific activity and
purification factor peaks coincided with the Imax peaks; however, the
maximum total protein concentration for all three fusions was eluted
at 0.25 M. For BGCDl and the wild type enzyme, the peak came at
0.3 M. BGCD5 showed a broader range spanning from 0.4 M to 0.5
M with an Imax at 0.45 M. Similarly, BGCDl 1 had a broad peak, its
maximum was at 0.55 M. An Imax value of0.3 M for commercial 13galactosidase shows that the purification fusion tails exhibit stronger
binding. More information about the elution steps can be derived
from figures 4, 5 and 6. The figures show the step gradient elution
profiles for BGCDl, BGCD5 and BGCDll respectively. Protein
concentration peaks can be seen at 0.25 M for all three tails. As seen
in figure 4, the fraction with the maximum specific activity had a
value of 350 U/mg. BGCD5 peaked at 400 U/ml and BGCDl at
700 U/ml as shown in figures 5 and 6.
To understand the level of enrichment each effluent sample had
obtained, the purification factor was calculated. The purification factor a is defined as the total specific activity divided by the specific
activity of the feed. The purification factor for BGCDl ranged from
2.5 to 5 throughout the tests with an average of 4.0. As with specific
activity, a increased with tail length. BGCD5 and an a of 4.5 and
BGCD 11 an average a of 7 .0. Figure 7 shows a step gradient elution
profile overlay with each fusion tail being represented. The different
specific activity peaks have a direct correlation with the purification
factor. Just as BGCDl 1 has the highest specific activity of the three
tails, it too has the highest a.
Throughout the testing, BGCDl 1 showed superior binding capabilities far exceeding those seen for BGCDl and BGCD5. Its high
specific activity brought upon by its longer tail led to a high purification factor. The difference in specific activity and purification factor
between BGCD5 and BGCDl 1 was substantially greater than that
between BGCDl and BGCD5. It was hypothesized that more
charges on the fusion tail yield stronger binding traits. Because
BGCDl 1 bound to the membrane much stronger than either
BGCDl or BGCD5, 11 aspartates in the tail could approach an optimal number for selective binding. Continued research with even
longer fusion tails would prove or disprove this hypothesis.
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Fig. 4. Step gradient elution profile for BGCDl cell extracts treated
using FMC QUAT.
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Fig. 5. Step gradient elution profile for BGCDS cell extracts treated
using FMC QUAT.
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Fig. 6. Step gradient elution profile for BGCDl 1 cell extracts treated
using FMC QUAT.
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fold enrichment of BGCD 11 from cell extracts through step gradient
elution. The product was recovered in an active state with a specific
activity level comparable to commercial ~-galactosidase. The intermediate partial elution procedure increased activity recovery by nearly 20%, however, no funher enrichment was witnessed.
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Fig. 7. Specific activity peaks increase with longer tail length. The
enzyme binds more strongly to the ion-exchange membrane with an
increasing number of aspartates in the tail.

CONCLUSIONS
In this work it was demonstrated that purification fusion tails can
be used to enhance separation and recovery on ion-exchange membranes. Selective enhancement increased with fusion tail length.
BGCDl 1 bound to the membrane most strongly followed by
BGCDS and BGCDl. The bind and release process brought seven-
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